Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma-Reference-Cited by-同舟云学术

Significant symptoms alleviation and tumor volume reduction after combined simultaneously integrated inner-escalated boost and volumetric-modulated arc radiotherapy in a patient with unresectable bulky hepatocellular carcinoma

Published:2016-08 Issue:34 Volume:95 Page:e4717
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Lin Young-Hsiang,Hung Shih-Kai,Chiou Wen-Yen,Lee Moon-Sing,Shen Bing-Jie,Chen Liang-Cheng,Liu Dai-Wei,Tsai Wei-Ta,Lin Po-Hao,Shih Yi-Ting,Hsu Feng-Chun,Tsai Shiang-Jiun,Chan Michael W.Y.,Lin Hon-Yi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference51 articles.

1. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

2. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

3. Cancer statistics for Hispanics/Latinos, 2015;Siegel;CA Cancer J Clin,2015

4. Interferon lambda and hepatitis C virus core protein polymorphisms associated with liver cancer;Moreira;Virology,2016

5. Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma;Lu;J Viral Hepat,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptidylarginine Deiminase Type 2 Predicts Tumor Progression and Poor Prognosis in Patients with Curatively Resected Biliary Tract Cancer;Cancers;2023-08-16

2. Impact of BRAFV600E Mutation on Event-Free Survival in Patients with Papillary Thyroid Carcinoma: A Retrospective Study in a Romanian Population;Cancers;2023-08-11

3. The tumor core boost study: A feasibility study of radical dose escalation to the central part of large tumors with an integrated boost in the palliative treatment setting;Strahlentherapie und Onkologie;2022-07-20

4. Role of modern radiotherapy in managing patients with hepatocellular carcinoma;World Journal of Gastroenterology;2021-05-28

5. OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs;Cells;2021-05-10